Transrectal Ultrasound Devices Market size was valued at USD 204.9 million in 2021. It is expected to reach a value of USD 291.3 million by 2028,at a CAGR of 4.6% from 2022-2028. Transrectal ultrasound devices are used to create an image of the organs in pelvis. Usually transrectal ultrasound devices are used to diagnose the pelvis and prostate gland. There are many types of ultrasound devices are present and are used in diagnosis of prostate cancer, prostatitis or benign prostatic hypertrophy. Transrectal ultrasound devices also used to guide the biopsy of prostate. Global transrectal ultrasound devices market is mainly driven by increase in the prevalence of prostate cancer and diseases related to pelvic region According to WHO GLOBOCAN 2012, prostate cancer is the fourth most common cancer in the both sexes an estimated 1.1 million men are diagnosed with the prostate cancer in 2012. In addition, growing awareness related to the symptoms of cancer due to the various initiatives were taken by government and non-government organizations coupled with adaptation of the new technologies by the hospitals in order to diagnose the diseases expected to boost the market share over the forecast period. Furthermore, technological advancements in the ultrasound technologies to provide the better pictures of the organs and advent of portable ultrasound devices are expected to bolster the market growth over the forecast period. However, stringent regulatory procedures and high cost of devices are expected to hamper the market growth over the forecast period.